2020-11-17T08:22:55-05:00 2020-06-30 474306215 Mullins PC 7625 Wisconsin Avenue Bethesda MD 20814 990 2019-07-01 411688677 International Society for Pharmacoepidemiology INTE 4800 Hampden Lane Bethesda MD 20814 James Vrac Executive Secre 3017186500 2020-11-16 true John Mullins P01429307 2027706371 2020-11-17 199.87.165.66 2020-11-17 08:49:46 7808122020322hvckmvh 2020-11-17 P 1B60FC6DCC588F6DEE433F7374BAB5DEB64CDD93 1B60FC6DCC588F6DEE433F7374BAB5DEB64CDD93 2019 2021-01-29 14:40:06Z X Almut Winterstein 2427831 false X www.pharmacoepi.org X 1989 NJ See Schedule O 21 21 0 0 0 0 1911940 2290071 120597 84628 0 2032537 2374699 112201 161158 0 0 0 0 1807881 1798487 1920082 1959645 112455 415054 4057343 3709080 877007 152002 3180336 3557078 See Schedule O false false 1568498 161158 2112169 Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk management, and other related fields. 2) Convene regular regional and local meetings on scientific and public policy issues, which currently includes a mid-year conference in conjunction with meetings of the board of directors and scientific program committee; and an annual Asian conference (ACPE) partnered with local scientific and professional societies. 110656 ISPEs volunteer organization comprises a diverse range of talents, demographics and professional experience necessary to promote both the leadership of the Society in pharmacoepidemiology and the knowledge-sharing that is fundamental to the advancement of pharmacoepidemiology, therapeutic risk management and other related fields. The Governance function supports: 1) The ISPE Board of Directors, a leadership group with international representation; 2) committees, councils, special interest groups, and national chapters; and 3) Student Council and Student Chapters (located at Schools of Pharmacy and Schools of Public Health). 82127 Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. 62714 The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; 2) a range of on-demand education sessions recorded at ISPE conferences and delivered via the Education Center; and 3) regular email updates to members on developments in pharmacoepidemiology, or about ISPE. 44708 177902 Membership: With membership of over 2000 in more than 50 countries, the Society is the voice of pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. Members gain access to a rich and formidable network of like-minded individuals entirely focused on these issues, combined with career mentoring and professional development. 107422 177902 1868703 true false false false false false false false false false true false false false false true true false false false true true false false false false false false false false false false false false false false false false false false false false false false false false false true 17 0 true 0 true false false false false false false false false false false false false X 21 21 false true false false true true true true true false false true true true true true true true true false X The Organization 3017186500 4800 Hampden Lane Bethesda MD 20814 X Almut Winterstein President 2.00 0.00 X X 0 0 0 Olaf Klungel President-Elect 2.00 0.00 X X 0 0 0 Alison Bourke Immediate Past President 2.00 0.00 X X 0 0 0 Krista Huybrechts VP Finance 2.00 0.00 X X 0 0 0 Pia Caduff Director 1.00 0.00 X 0 0 0 Vera Ehrenstein Director 1.00 0.00 X 0 0 0 Cynthia Girman Director 1.00 0.00 X 0 0 0 Chieko Ishiguro Director 1.00 0.00 X 0 0 0 Michele Jonsson Funk Director 1.00 0.00 X 0 0 0 Ursula Kirchmayer Director 1.00 0.00 X 0 0 0 Malcolm Maclure Director 1.00 0.00 X 0 0 0 Lisa Pont Director 1.00 0.00 X 0 0 0 Deborah Layton Director 1.00 0.00 X 0 0 0 Jennita Reefhuis Director 1.00 0.00 X 0 0 0 Fredrik Nyberg Director 1.00 0.00 X 0 0 0 Montserrat Soriano Gabarro Director 1.00 0.00 X 0 0 0 Darren Toh Director 1.00 0.00 X 0 0 0 Jasmanda HsiaoHui Wu Director 1.00 0.00 X 0 0 0 Stanley Edlavitch Executive Director Emeritus 1.00 0.00 X 0 0 0 Wei Zhou VP Finance-Elect 2.00 0.00 X X 0 0 0 Mary Ritchey Director 1.00 0.00 X 0 0 0 James Vrac Executive Secretary 20.00 0.00 X 0 0 0 0 0 0 0 false false false PAI Management Corporation 4800 Hampden Lane Bethesda MD 20814 Management 508748 Aramark 1101 Arch St Philadelphia PA 19107 Catering 400313 KMC GMBH Sonnenallee 225 Berlin Germany GM 12057 Facilities Rental 230933 3 Membership Dues 900099 177902 177902 Conferences Meetings 900099 2112169 2112169 2290071 47760 47760 90000 53132 36868 36868 36868 2374699 2290071 0 84628 161158 161158 436010 401070 34940 18404 18404 69322 69322 3031 3031 79302 76294 3008 91383 91383 53391 53391 876059 875252 807 10122 10122 6561 4328 2233 Bank and Credit Card Fees 65084 62596 2488 Special Projects 49189 49189 Other 40629 11567 29062 1959645 1868703 90942 0 990931 215480 341200 732273 107840 104934 13029 2906 2712183 2758421 4057343 3709080 47614 42812 829393 109190 877007 152002 X 3180336 3557078 3180336 3557078 4057343 3709080 415054 -38312 0 X false true X true false X 236135 228080 925 465140 1601391 1355620 1690159 1911940 2290071 8849181 1837526 1583700 1691084 1911940 2290071 9314321 9314321 64411 79577 58757 120597 47760 371102 64411 79577 58757 120597 47760 371102 1901937 1663277 1749841 2032537 2337831 9685423 0.96170 0.95530 0.04000 0.04000 X 15390 15317 73 92450 89617 2833 2906 X 2336387 -38312 -38312 2374699 2374699 1959645 1959645 1959645 Footnote for uncertain tax position under FIN 48 (Part X) ISPE is exempt from the payment of income taxes on its exempt activities under Section 501(c)(3) of the Internal Revenue Code. ISPE follows the Financial Accounting Standards Board Accounting Standards Codification, which provides guidance on accounting for uncertainty in income taxes recognized in ISPEs financial statements, if any. At year end, ISPE had no unrecognized tax benefits related to uncertain tax positions in its information return that would qualify for either recognition or disclosure in its financial statements. ISPEs policy would be to recognize interest and penalties on tax positions related to its unrecognized tax benefits in income tax expense in the financial statements. Through year end, there have been no matters that would have resulted in an accrual for interest and/or penalties. Generally, the tax years before 2017 are no longer subject to examination by federal, state, or local taxing authorities. true Sub-Saharan Africa Program services Meetings 5000 East Asia and the Pacific Program services Meetings 41340 46340 46340 East Asia and the Pacific 43861 Sub-Saharan Africa 4000 false false false false false false Use of grant monitoring procedures (Part I, line 2) The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. The annual and mid-year meetings provide a point of contact for the exchange of information among the meeting participants. Stanley A Edlavitch award most highly rated student abstracts the Stanley A Edlavitch award, created by the board student who submits the most highly rated abstract for presentation of the meeting, and consists of a certificate and a financial award to defray the costs of transportation, housing, and food, and a complimentary registration to the annual meeting. Andrew McAfee award best abstract from a developing country. The Andrew McAfee award commemorates a passionate teacher, drug safety researcher and long-time active participant and supporter of ISPE who died in a tragic accident in 2010. It is awarded for the best abstract submitted from a researcher or student living in a developing country (as defined by UN guidelines). The award consists of free admission to the annual ISPE meeting, to any associated educational sessions, a scholarship to attend the meeting, and a plaque. The recipients will be selected by the scientific program committee, and the scholarship committee will administer the award the amount of the scholarship will be determined by the scholarship committee in accordance with principles laid down in the ISPE policy manual concerning costs covered by developing world scholarship awards (technical appendix c). Costs associated with the Andrew McAfee award would be independent of and in addition to the budgeted funds associated with ISPE scholarships. Management duties delegation Part VI line 3 Effective January 2000, ISPE entered into an agreement with PAI Management Corporation, an association management company, to receive management and administrative services. Thisagreement may be terminated by either ISPE or the management company, upon proper notification, given a 90-day notification. Currently, the agreement will remain in effect until one of the parties gives notice of cancellation. As stated in the contract, any amendments to fees are approved through the annual ISPE budget. Members or stockholder classes and rights Part VI line 6 Members are individuals or organizations dedicated to pharmacoepidemiology research, education, and practice and its related description lines, and demonstrates and interest in promoting the growth of this field. All members have voting rights. Member election for additional members Part VI line 7a Every member has the right to elect members of the Organizations governing body. Governing body decisions Part VI line 7b The by-laws may be amended or repealed by action of the Board of Directors or by action of the general members. Form 990 governing body review Part VI line 11 Form 990 is prepared by an outside independent certified public accounting firm and submitted to senior ISPE management and PAI staff prior to distribution to ISPEs Board of Directors. A draft of Form 990 is sent to the Board of Directors with a final version available to the board after it is filed with the IRS. Conflict of interest policy compliance Part VI line 12c Conflict of interest discussed and resolved on a case by case basis as situations which could cause conflicts arise. CEO executive director top management comp Part VI line 15a Compensation of ISPEs Executive Secretary is paid by PAI Management Corporation through a management services contract (in lieu of full time professional staff) under which PAI provides a scope of management, technology and accounting services which is agreed upon and approved on a yearly basis by the Board of Directors. Other officer or key employee compensation Part VI line 15b ISPE operates under a management services contract with PAI Management Corporation in lieu of full time professional staff. Governing documents etc available to public Part VI line 19 The Organization makes it governing documents, conflict of interest policy, and financial statements available to the public upon request. General explanation attachment Mission Statement:The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.